On July 9, 2025, the FDA released its decision to approve the supplemental Biologics License Application (BLA) for SPIKEVAX, but only for certain ages at high risk.
Here’s what you need to know about the study, Effectiveness of the Influenza Vaccine During the 2024-2025 Respiratory Viral Season.
The American Academy of Pediatrics (AAP) is updating the roster of Chapter Immunization Representatives (CIRs) and is seeking to maintain an updated listing.
A look at a recent study, Long-term Dynamics of Measles Virus–Specific Neutralizing Antibodies in Children Vaccinated Before 12 Months of Age.
AIM held eight listening sessions with immunization PMs during the VAC Regional Meetings for adult immunization from May-July 2024.
AIM invites participation in its Immunization Program and Birthing Institution Community of Practice (CoP) to Optimize Administration of Birth Dose Immunizations.
A study found that 15.4% of children ages 0 to 35 months received at least one invalid vaccine dose.
A study published in the February 5, 2025, issue of Pediatrics, "Cost Analysis of a Scalable Clinician Communication Intervention to Increase HPV Vaccine…
A study found that combining provider education with other interventions has the potential to significantly improve HPV vaccine initiation rates.
Explore AIM’s one-pager about collaboration opportunities between immunization programs (IPs) and maternal child health (MCH) programs.